Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.healun.2017.06.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
International Society for Heart and Lung Transplantation (ISHLT) Consensus Statement on Risk Stratification in Pulmonary Arterial Hypertension.
J Heart Lung Transplant
August 2025
Cardiology Eastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, George and Linda Kaufman Academic Chair of Cardiology, Sentara Health 825 Fairfax Ave, Suite 563 Norfolk, Virginia 23507. Electronic address:
Indications for pediatric lung transplantation in 2025: A new era.
JHLT Open
August 2025
Division of Pediatric Pulmonology, Boston Children's Hospital and Harvard Medical School, Boston, MA.
The year 2025 marks an important landmark: almost 40 years since the first pediatric lung transplant (LTX), over 3-5 years since the availability of elexacaftor/tezacaftor/ivacaftor in several countries, and 5-10 years since striking shifts were reported in the diagnoses that accounted for pediatric LTX. We review historic indications for pediatric LTX, highlighting shifts in these over time, and analyze data from the ISHLT International Thoracic Organ Transplant Registry, United Network of Organ Sharing, Canadian Cystic Fibrosis (CF) Registry, and other databases up to the present day. Currently, pediatric CF-related LTX cases are at record lows in many countries.
View Article and Find Full Text PDFSummary of the International Society for Heart and Lung Transplantation consensus conference on emerging understanding of antibodies and antibody-mediated rejection in heart transplantation.
J Heart Lung Transplant
August 2025
Cedars-Sinai Smidt Heart Institute, Los Angeles, California.
The understanding of circulating antibodies and their relationship to antibody-mediated rejection (AMR) has yet to be fully elucidated in heart transplantation. Circulating antibodies are important in both pretransplant and post-transplant. In the pretransplant period, the more antibodies detected in a patient awaiting heart transplantation often significantly reduces the chance of obtaining a compatible donor heart.
View Article and Find Full Text PDFISHLT consensus statement on the perioperative use of ECLS in lung transplantation: Part III: Postoperative considerations.
J Heart Lung Transplant
April 2025
Respiratory and Transplant Medicine, Royal Brompton and Harefield Hospitals, Part of Guy's and St Thomas' NHS Foundation Trust and Imperial College London, London, UK.
The use of extracorporeal life support (ECLS) throughout the perioperative phase of lung transplantation requires nuanced planning and execution by an integrated team of multidisciplinary experts. To date, no multidisciplinary consensus document has examined the perioperative considerations of how to best manage these patients. To address this challenge, this perioperative utilization of ECLS in lung transplantation consensus statement was approved for development by the International Society for Heart and Lung Transplantation Standards and Guidelines Committee.
View Article and Find Full Text PDFCardiac positron emission tomography/Computed tomography (PET/CT) in current cardiology guidelines.
J Nucl Cardiol
June 2025
Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA. Electronic address:
Cardiac positron emission tomography (PET) is increasingly utilized in clinical practice. This review examines the latest clinical practice guidelines from the American College of Cardiology/American Heart Association (ACC/AHA), the European Society of Cardiology (ESC), the International Society for Heart and Lung Transplantation (ISHLT), and multisocietal consensus statements as of December 2024, to assess the extent to which cardiac PET is incorporated into their recommendations.
View Article and Find Full Text PDF